Therapeutic Potential of Arimoclomol Nanomicelles: In Vitro Impact on Alzheimer’s and Parkinson’s Pathology and Correlation with In Vivo Inflammatory Response
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.4c00734 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Isabelle Xavier-de-Britto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de…. Hauptthemen laut MEDLINE: Alzheimer Disease, Parkinson Disease, Inflammation, Anti-Inflammatory Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Funda??o Carlos Chagas Filho de Amparo ? Pesquisa do Estado do Rio de Janeiro.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, Rio de Janeiro 21941906, Brazil.
- Laboratory of Biological Chemistry of Neurodegenerative Disorders, Department of Physical Chemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
- Biophysics and Nanosystems Laboratory, Federal University of Maranhão, Department of Physics, São Luis, Maranhão 65065690, Brazil.
- Laboratory of Microscopy Applied to Life Science-Lamav, National Institute of Metrology, Quality and Technology, Duque de Caxias, Rio de Janeiro 25250-020, Brazil.
- Laboratory of Inflammation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.
- Federal University of Rio de Janeiro, School of Pharmacy, Rio de Janeiro, Rio de Janeiro 21941900, Brazil.
ORCID-Profile: Natália Cristina Gomes-da-Silva, Luciana Magalhães Rebelo Alencar, Pierre Basílio Almeida Fechine, Ralph Santos-Oliveira
Förderung
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
- Funda??o Carlos Chagas Filho de Amparo ? Pesquisa do Estado do Rio de Janeiro
Zitieren
APA
Xavier-de-Britto, I., Gomes-da-Silva, N. C., Gomes Soares, M. A., Follmer, C., Dabkiewicz, D., Alencar, L. M. R., Sant'Anna, C., Ferreira, T. P. T., Martins, P. M. R. E. S., Ricci-Junior, E., Fechine, P. B. A., & Santos-Oliveira, R. (2025). Therapeutic Potential of Arimoclomol Nanomicelles: In Vitro Impact on Alzheimer’s and Parkinson’s Pathology and Correlation with In Vivo Inflammatory Response. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00734
Vancouver
Xavier-de-Britto I, Gomes-da-Silva NC, Gomes Soares MA, Follmer C, Dabkiewicz D, Alencar LMR, et al. Therapeutic Potential of Arimoclomol Nanomicelles: In Vitro Impact on Alzheimer’s and Parkinson’s Pathology and Correlation with In Vivo Inflammatory Response. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00734
BibTeX
@article{XavierdeBritto2025,
author = {Xavier-de-Britto, Isabelle and Gomes-da-Silva, Natália Cristina and Gomes Soares, Marilia Amável and Follmer, Cristian and Dabkiewicz, David and Alencar, Luciana Magalhães Rebelo and Sant'Anna, Celso and Ferreira, Tatiana Paula Teixeira and Martins, Patrícia Machado Rodrigues E Silva and Ricci-Junior, Eduardo and Fechine, Pierre Basílio Almeida and Santos-Oliveira, Ralph},
title = {Therapeutic Potential of Arimoclomol Nanomicelles: In Vitro Impact on Alzheimer’s and Parkinson’s Pathology and Correlation with In Vivo Inflammatory Response},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.4c00734}
}
EUVIMED